One of the most common questions patients ask about fat graft breast augmentation is:

“How much of the transferred fat will survive?”
“Will I develop lumps?”

In reality, these are the two most important factors that determine the quality of a fat grafting procedure.

• How much of the transferred fat can survive long-term?
• How can we minimize the risk of fat necrosis and palpable lumps?

At AVAN TOKYO, these questions are at the center of how we approach fat graft breast augmentation.

One of the most promising developments in regenerative medicine is the use of adipose-derived stem cells (ADSCs) through a technique known as Cell-Assisted Lipotransfer (CAL).

In the future, AVAN TOKYO plans to incorporate adipose-derived stem cell therapy not only for breast augmentation, but also for knee joint regeneration, hair restoration, and skin rejuvenation.

What Is Cell-Assisted Lipotransfer (CAL)?

Cell-Assisted Lipotransfer (CAL) is an advanced regenerative medicine technique that combines conventional fat grafting with adipose-derived stem cells.

Instead of transferring fat alone, the procedure involves:

• Harvesting fat tissue
• Isolating adipose-derived stem cells
• Expanding these cells through cell culture
• Reinjecting the cultured stem cells together with purified fat

The concept is not simply to add more fat, but to create a biological environment that may improve fat survival.

What Are Adipose-Derived Stem Cells?

Fat tissue contains two major cell populations:

• Mature adipocytes (fat cells)
• Adipose-derived stem cells (ADSCs)

While mature fat cells provide volume, adipose-derived stem cells possess regenerative properties, including:

• Self-renewal
• Multipotent differentiation

Experimental studies have shown that ADSCs can differentiate into multiple cell types, including:

• Adipocytes
• Endothelial cells
• Cartilage cells
• Bone cells

These characteristics make them an important focus of regenerative medicine research.

Why Might Stem Cells Improve Fat Graft Survival?

Immediately after fat grafting, the transferred fat has no direct blood supply.

Its survival depends on how quickly new blood vessels develop around the graft.

Laboratory and preclinical studies suggest that adipose-derived stem cells secrete important growth factors, including:

• Vascular Endothelial Growth Factor (VEGF)
• Hepatocyte Growth Factor (HGF)

These factors may promote angiogenesis—the formation of new blood vessels—which helps deliver oxygen and nutrients to transplanted fat cells.

ADSCs may also contribute by differentiating into vascular endothelial cells, further supporting the establishment of a healthy blood supply.

Together, these mechanisms may improve long-term fat graft survival.

Could CAL Help Reduce Lumps?

One of the concerns following fat graft breast augmentation is the formation of:

• Fat necrosis
• Calcification
• Fibrosis
• Palpable lumps

When transplanted fat does not survive, inflammatory and fibrotic changes can occur.

Research suggests that adipose-derived stem cells may influence tissue repair and inflammatory responses, potentially reducing excessive fibrosis.

This has led to growing interest in whether CAL may help decrease the incidence of palpable nodules following fat grafting.

However, this remains an active area of research, and further long-term clinical studies are needed.

Why Is CAL Especially Interesting for Hybrid Breast Augmentation?

At AVAN TOKYO, hybrid breast augmentation is one of our signature procedures.

For patients with silicone implants, the most important areas are often:

• The cleavage
• The upper pole (décolletage)

These areas determine how natural the breast appears.

Fat grafting is frequently used to soften implant edges and improve these contours.

By combining fat grafting with adipose-derived stem cells, we hope to further optimize fat survival in these critical aesthetic areas and achieve longer-lasting, more natural results.

Surgery Alone Is Not Enough

Even with advanced surgical techniques, postoperative care remains essential.

Patients can help optimize fat survival by:

• Avoiding smoking
• Maintaining a balanced diet
• Preventing significant weight loss during healing
• Following all postoperative instructions carefully

Excellent surgical technique and proper recovery work together to achieve the best possible outcome.

The Future of Regenerative Medicine at AVAN TOKYO

Our goal is not simply to perform breast augmentation.

We aim to combine aesthetic surgery with regenerative medicine to improve both the quality and longevity of our results.

Areas we plan to expand include:

• Cell-Assisted Lipotransfer (CAL) for breast augmentation
• Regenerative treatment for knee osteoarthritis
• Hair restoration using adipose-derived stem cells
• Skin rejuvenation and tissue regeneration

Next week, I will be attending a regenerative medicine meeting in Los Angeles to learn the latest scientific developments in stem cell therapy and explore how these advances may be safely integrated into clinical practice.

Risks and Important Considerations

Fat graft breast augmentation and stem cell-based regenerative therapies carry potential risks, including swelling, bruising, pain, infection, hematoma, fat resorption, fat necrosis, calcification, fibrosis, palpable lumps, asymmetry, scarring, and the possible need for revision surgery.

While Cell-Assisted Lipotransfer has shown promising results in experimental studies and selected clinical reports, long-term evidence is still evolving. Its effectiveness may vary between individuals, and ongoing research is necessary to better define its long-term safety and clinical benefits.

Surgeon’s Message

The success of fat graft breast augmentation is not determined by how much fat is injected.

What truly matters is how much healthy tissue survives and how naturally it integrates over time.

At AVAN TOKYO, we combine anatomy-based surgical techniques with the latest advances in regenerative medicine to pursue safer, more natural, and longer-lasting outcomes.

Cell-Assisted Lipotransfer represents one of the most exciting frontiers in breast augmentation, and we are committed to continuously evaluating new scientific evidence so we can provide our patients with advanced treatments supported by the latest medical knowledge.